None listed
Conditions
Interventions
None listed
Sponsors
National Cancer Center Hospital
Flatiron Health K.K.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria will be included in this study. - Patients who received care at the National Cancer Center Hospital between the commencement of this research and December 31, 2028 - Patients with a confirmed or suspected diagnosis of any of the following tumor types: - Lung cancer (non-small cell lung cancer, small cell lung cancer, etc.) - Gastrointestinal cancers (esophageal cancer, gastroesophageal junction cancer, gastric cancer, colorectal cancer, hepatocellular carcinoma, pancreatic cancer, gallbladder cancer, duodenal papillary carcinoma, intrahepatic bile duct cancer, gastrointestinal stromal cancer, small bowel cancer (including duodenal cancer), primary neuroendocrine tumor of the digestive tract, etc.) - Breast cancer - Hematological malignancies (leukemia, malignant lymphoma, multiple myeloma, myeloproliferative disorders, etc.) - Patients aged 18 and above - Patients who provided appropriate consent (or by surrogate consent) to participate in this study - Surrogates include the patient's spouse, parent, sibling, children or grandchildren, grandparents, cohabiting relatives or other equivalent next-of-kin (excluding minors)
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Real-world overall survival, time-to-next-treatment, progression-free survival, time-to-treatment-discontinuation etc. | — |
Countries
Japan
Contacts
Public ContactYasushi Goto
National Cancer Center Hospital Department of Thoracic Oncology
Outcome results
None listed